JPMorgan analyst Brian Essex initiated coverage of Rapid7 with a Neutral rating and $38 price target. The analyst believes vulnerability assessment and management may fall lower on spending priority lists heading into a challenging macro environment in 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RPD:
- Rapid7 initiated with a Neutral at DA Davidson
- Rapid7 to Report Fourth Quarter and Full Year 2022 Financial Results on February 8
- Rapid7 price target lowered to $45 from $50 at Piper Sandler
- Rapid7 downgraded to Equal Weight from Overweight at Barclays
- Rapid7 price target lowered to $40 from $45 at Mizuho